Havrix 1440
Details for Havrix 1440 vaccine and its components.
Sponsor:
GlaxoSmithKline Australia
Administration route:
Intramuscular injection
Vaccine group:
Monovalent vaccines
Registered for use in people aged ≥16 years.
Each 1.0 mL monodose vial or pre-filled syringe contains:
- 1440 ELISA units of inactivated hepatitis A virus (HM175 strain)
- 0.5 mg aluminium as aluminium hydroxide
Also contains traces of:
- formaldehyde
- neomycin
- polysorbate 20
For full details, refer to the product information and consumer medicine information sheets for Havrix vaccine available on the TGA website.
Page history
Last updated:
4 June 2018
Last reviewed:
4 June 2018
Definitions
- ELISA
- enzyme-linked immunosorbent assay
Printed content may be out of date. For up to date information, always refer to the digital version: https://immunisationhandbook.health.gov.au/vaccines/havrix-1440.